The hospitality industry has historically been male-dominated. Women make up most of the workforce but don’t hold the majority of decision-makers. In upper-tier companies, only 20% of executives are women, and just 8% of the directors, according to the Hospitality Industry Pipeline Coalition.

Former President Donald Trump and Vice President Kamala Harris are neck and neck in the swing state of Nevada with less than two months to go until the November election, new polling shows.

Former President Donald Trump and Vice President Kamala Harris are neck and neck in the swing state of Nevada with less than two months to go until the November election, new polling shows.

Regulating the Game, a leading global conference on gambling law and regulation, has announced Dr. Marla Royne Stafford as the first Conference Chair for its 2025 edition, to be held in Sydney from March 10 to 13, 2025.

The California Supreme Court put the brakes on the State Bar of California’s plan to launch a proprietary bar exam created by Kaplan Exam Services in February 2025.

When we think creatively or have “Eureka” moments, we may actually unlock access to a dimension outside of our everyday perception, according to the controversial theory.

As Southern Nevada continues its efforts on water conservation, UNLV is hoping to create a solution to Southern Nevada’s water shortage with its newest device to harvest atmospheric water vapor.

The Las Vegas Sinfonietta, a professional chamber orchestra, will kick off its fifth concert season this weekend with a historically significant performance. The season’s opening concert, “Violins of Hope,” is a powerful tribute to the resilience and spirit of Holocaust survivors.

The Alzheimer's Drug Discovery Foundation (ADDF) today announced a new investment to develop a first-of-its-kind Biomarker Observatory that will provide a comprehensive overview of the Alzheimer's biomarkers pipeline, including blood tests, brain scans, digital devices, and other tools that can help diagnose and monitor the disease. These efforts will be led by renowned clinical trialist Jeffrey Cummings, MD, ScD, Joy Chambers-Grundy Professor of Brain Science at the School of Integrated Health Sciences at University of Nevada, Las Vegas with Co-Principal Investigator Feixiong Cheng, PhD, from the Laboratory of Network Medicine at Cleveland Clinic. This Observatory will fill a critical gap by creating the first thorough overview of the biomarker pipeline, serving as a key resource to catalyze progress in drug development.